|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K 35/17 | (2015.01) | ||
| A61K 31/436 | (2006.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Patento numeris | 3888674 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21160203.2 |
| Europos patento paraiškos padavimo data | 2015-04-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-10-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-04-03 |
| (46) | Apibrėžties vertimo paskelbimo data | 2024-07-25 |
| (30) | Numeris | Data | Šalis |
| 201461976396 P | 2014-04-07 | US | |
| 201462007309 P | 2014-06-03 | US | |
| 201462036493 P | 2014-08-12 | US | |
| 201462076238 P | 2014-11-06 | US | |
| 201462087888 P | 2014-12-05 | US | |
| 201462097278 P | 2014-12-29 | US |
| (72) |
BYRD, John , US
DUBOVSKY, Jason , US
FRAIETTA, Joseph , US
GILL, Saar , US
GLASS, David , US
JOHNSON, Amy , US
JUNE, Carl H. , US
KENDERIAN, Saad , US
MANNICK, Joan , US
MAUS, Marcela , US
MURPHY, Leon , US
MUTHUSAMY, Natarajan , US
PORTER, David L. , US
RUELLA, Marco , US
SELLERS, William Raj , US
WASIK, Mariusz , US
BROGDON, Jennifer , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
The Trustees of The University of Pennsylvania , 3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US |
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Vėžio gydymas naudojant anti-CD19 chimerinį antigeno receptorių |
| TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-03-18 | 11 | 289.00 EUR |
| 2026-04-07 |